{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:08:34Z","timestamp":1767143314514,"version":"build-2238731810"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T00:00:00Z","timestamp":1629072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T00:00:00Z","timestamp":1629072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s13300-021-01133-8","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T06:02:57Z","timestamp":1629093777000},"page":"2857-2870","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study"],"prefix":"10.1007","volume":"12","author":[{"given":"Rifat","family":"Emral","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cem","family":"Haymana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Demirci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilker","family":"Tasci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erman","family":"Cakal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naim","family":"Ata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ugur","family":"Unluturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tevfik","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derun","family":"Ertugrul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayseg\u00fcl","family":"Atmaca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman","family":"Celik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Caglayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazim Yalcin","family":"Arga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selcuk","family":"Dagdelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serpil","family":"Salman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilhan","family":"Satman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alper","family":"Sonmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,16]]},"reference":[{"issue":"25","key":"1133_CR1","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1056\/NEJMoa2007621","volume":"382","author":"MR Mehra","year":"2020","unstructured":"Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular disease, drug therapy, and mortality in COVID-19. N Engl J Med. 2020;382(25):e102.","journal-title":"N Engl J Med"},{"issue":"5","key":"1133_CR2","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.kint.2020.03.005","volume":"97","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829\u201338.","journal-title":"Kidney Int"},{"issue":"11","key":"1133_CR3","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/1753-0407.13091","volume":"12","author":"G Aggarwal","year":"2020","unstructured":"Aggarwal G, Lippi G, Lavie CJ, Henry BM, Sanchis-Gomar F. Diabetes mellitus association with coronavirus disease 2019 (COVID-19) severity and mortality: a pooled analysis. J Diabetes. 2020;12(11):851\u20135.","journal-title":"J Diabetes"},{"issue":"4","key":"1133_CR4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.dsx.2020.04.018","volume":"14","author":"I Huang","year":"2020","unstructured":"Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia\u2014a systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. 2020;14(4):395\u2013403.","journal-title":"Diabetes Metab Syndr"},{"issue":"7","key":"1133_CR5","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.2337\/dc20-0682","volume":"43","author":"F Gao","year":"2020","unstructured":"Gao F, Zheng KI, Wang XB, Sun QF, Pan KH, Wang TY, et al. Obesity is a risk factor for greater COVID-19 severity. Diabetes Care. 2020;43(7):e72\u20134.","journal-title":"Diabetes Care"},{"issue":"6","key":"1133_CR6","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.cmet.2020.04.021","volume":"31","author":"L Zhu","year":"2020","unstructured":"Zhu L, She ZG, Cheng X, Qin JJ, Zhang XJ, Cai J, et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020;31(6):1068\u20131077.e3. https:\/\/doi.org\/10.1016\/j.cmet.2020.04.021.","journal-title":"Cell Metab."},{"issue":"11","key":"1133_CR7","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1007\/s00125-020-05216-2","volume":"63","author":"C Sardu","year":"2020","unstructured":"Sardu C, D\u2019Onofrio N, Balestrieri ML, et al. Hyperglycaemia on admission to hospital and COVID-19. Diabetologia. 2020;63(11):2486\u20137.","journal-title":"Diabetologia"},{"issue":"1","key":"1133_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.dsx.2020.12.026","volume":"15","author":"AK Singh","year":"2020","unstructured":"Singh AK, Singh R, Saboo B, Misra A. Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: a critical appraisal of literature. Diabetes Metab Syndr Clin Res Rev. 2020;15(1):159\u201367.","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"issue":"1","key":"1133_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cei.12781","volume":"185","author":"C Klemann","year":"2016","unstructured":"Klemann C, Wagner L, Stephan M, von H\u00f6rsten S. Cut to the chase: a review of CD26\/dipeptidyl peptidase-4\u2019s (DPP4) entanglement in the immune system. Clin Exp Immunol. 2016;185(1):1\u201321.","journal-title":"Clin Exp Immunol"},{"key":"1133_CR10","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3389\/fphar.2020.01161","volume":"11","author":"I Valencia","year":"2020","unstructured":"Valencia I, Peir\u00f3 C, Lorenzo \u00d3, S\u00e1nchez-Ferrer CF, Eckel J, Romacho T. DPP4 and ACE2 in diabetes and COVID-19: therapeutic targets for cardiovascular complications? Front Pharmacol. 2020;11:1161.","journal-title":"Front Pharmacol"},{"issue":"7","key":"1133_CR11","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/1753-0407.13171","volume":"13","author":"A Sonmez","year":"2021","unstructured":"Sonmez A, Demirci I, Haymana C, et al. Clinical characteristics and outcomes of COVID-19 in patients with type 2 diabetes in Turkey: a nationwide study (TurCoviDia). J Diabetes. 2021;13(7):585\u201395.","journal-title":"J Diabetes."},{"key":"1133_CR12","doi-asserted-by":"publisher","first-page":"108753","DOI":"10.1016\/j.diabres.2021.108753","volume":"174","author":"I Satman","year":"2021","unstructured":"Satman I, Demirci I, Haymana C, et al. Unexpectedly lower mortality rates in COVID-19 patients with and without type 2 diabetes in Istanbul. Diabetes Res Clin Pract. 2021;174:108753.","journal-title":"Diabetes Res Clin Pract"},{"issue":"9","key":"1133_CR13","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604.","journal-title":"Ann Intern Med"},{"issue":"6","key":"1133_CR14","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1210\/er.2014-1035","volume":"35","author":"EE Mulvihill","year":"2014","unstructured":"Mulvihill EE, Drucker DJ. Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors. Endocr Rev. 2014;35(6):992\u20131019.","journal-title":"Endocr Rev"},{"issue":"1","key":"1133_CR15","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/22221751.2020.1739565","volume":"9","author":"N Vankadari","year":"2020","unstructured":"Vankadari N, Wilce JA. Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg Microbes Infect. 2020;9(1):601\u20134.","journal-title":"Emerg Microbes Infect"},{"issue":"9","key":"1133_CR16","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/1753-0407.13052","volume":"12","author":"MF Bassendine","year":"2020","unstructured":"Bassendine MF, Bridge SH, McCaughan GW, Gorrell MD. COVID-19 and comorbidities: a role for dipeptidyl peptidase 4 (DPP4) in disease severity? J Diabetes. 2020;12(9):649\u201358.","journal-title":"J Diabetes"},{"issue":"7440","key":"1133_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nature12005","volume":"495","author":"VS Raj","year":"2013","unstructured":"Raj VS, Mou H, Smits SL, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013;495(7440):251\u20134.","journal-title":"Nature"},{"issue":"24","key":"1133_CR18","doi-asserted-by":"publisher","first-page":"13892","DOI":"10.1128\/JVI.02448-13","volume":"87","author":"K Ohnuma","year":"2013","unstructured":"Ohnuma K, Haagmans BL, Hatano R, et al. Inhibition of middle east respiratory syndrome coronavirus Infection by anti-CD26 monoclonal antibody. J Virol. 2013;87(24):13892\u20139.","journal-title":"J Virol"},{"key":"1133_CR19","doi-asserted-by":"publisher","first-page":"108125","DOI":"10.1016\/j.diabres.2020.108125","volume":"162","author":"G Iacobellis","year":"2020","unstructured":"Iacobellis G. COVID-19 and Diabetes: can DPP4 inhibition play a role? Diabetes Res Clin Pract. 2020;162:108125.","journal-title":"Diabetes Res Clin Pract"},{"key":"1133_CR20","doi-asserted-by":"publisher","first-page":"108216","DOI":"10.1016\/j.diabres.2020.108216","volume":"164","author":"R Dalan","year":"2020","unstructured":"Dalan R. Is DPP4 inhibition a comrade or adversary in COVID-19 infection. Diabetes Res Clin Pract. 2020;164:108216.","journal-title":"Diabetes Res Clin Pract"},{"issue":"12","key":"1133_CR21","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.2337\/dc20-1521","volume":"43","author":"SB Solerte","year":"2020","unstructured":"Solerte SB, D\u2019Addio F, Trevisan R, et al. Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and COVID-19: a multicenter, case-control, retrospective, observational study. Diabetes Care. 2020;43(12):2999\u20133006.","journal-title":"Diabetes Care."},{"issue":"12","key":"1133_CR22","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.2337\/dc20-1340","volume":"43","author":"M Mirani","year":"2020","unstructured":"Mirani M, Favacchio G, Carrone F, et al. Impact of comorbidities and glycemia at admission and dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes with COVID-19: a case series from an Academic Hospital in Lombardy, Italy. Diabetes Care. 2020;43(12):3042\u20139.","journal-title":"Italy. Diabetes Care."},{"issue":"7","key":"1133_CR23","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.2337\/dc20-0660","volume":"43","author":"Y Chen","year":"2020","unstructured":"Chen Y, Yang D, Cheng B, et al. Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication. Diabetes Care. 2020;43(7):1399\u2013407.","journal-title":"Diabetes Care"},{"issue":"10","key":"1133_CR24","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1111\/dom.14097","volume":"22","author":"GP Fadini","year":"2020","unstructured":"Fadini GP, Morieri ML, Longato E, et al. Exposure to dipeptidyl-peptidase-4 inhibitors and COVID-19 among people with type 2 diabetes: a case-control study. Diabetes Obes Metab. 2020;22(10):1946\u201350.","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"1133_CR25","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.2337\/dc20-1824","volume":"44","author":"Y Noh","year":"2021","unstructured":"Noh Y, Oh I-S, Jeong HE, Filion KB, Yu OHY, Shin J-Y. Association between DPP-4 inhibitors and COVID-19\u2013related outcomes among patients with type 2 diabetes. Diabetes Care. 2021;44(4):e64\u20136.","journal-title":"Diabetes Care"},{"issue":"1","key":"1133_CR26","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s12916-020-01832-2","volume":"18","author":"LM P\u00e9rez-Belmonte","year":"2020","unstructured":"P\u00e9rez-Belmonte LM, Torres-Pe\u00f1a JD, L\u00f3pez-Carmona MD, et al. Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: A nationwide cohort study. BMC Med. 2020;18(1):359.","journal-title":"BMC Med"},{"issue":"5","key":"1133_CR27","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/dom.14324","volume":"23","author":"R Roussel","year":"2021","unstructured":"Roussel R, Darmon P, Pichelin M, et al. Use of dipeptidyl peptidase-4 inhibitors and prognosis of COVID-19 in hospitalized patients with type 2 diabetes: a propensity score analysis from the CORONADO study. Diabetes Obes Metab. 2021;23(5):1162\u201372.","journal-title":"Diabetes Obes Metab"},{"issue":"22","key":"1133_CR28","doi-asserted-by":"publisher","first-page":"5576","DOI":"10.12998\/wjcc.v8.i22.5576","volume":"8","author":"J-H Zhou","year":"2020","unstructured":"Zhou J-H, Wu B, Wang W-X, et al. No significant association between dipeptidyl peptidase-4 inhibitors and adverse outcomes of COVID-19. World J Clin Cases. 2020;8(22):5576\u201388.","journal-title":"World J Clin Cases"},{"issue":"2","key":"1133_CR29","first-page":"396","volume":"31","author":"SG Antonio","year":"2020","unstructured":"Antonio SG, Matteo M, Achille C, et al. Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily. Nutr Metab Cardiovasc Dis. 2020;31(2):396\u20138.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"12","key":"1133_CR30","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.2337\/dci20-0062","volume":"43","author":"MA Nauck","year":"2020","unstructured":"Nauck MA, Meier JJ. Reduced COVID-19 mortality with sitagliptin treatment? Weighing the dissemination of potentially lifesaving findings against the assurance of high scientific standards. Diabetes Care. 2020;43(12):2906\u20139.","journal-title":"Diabetes Care."},{"issue":"4","key":"1133_CR31","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.therap.2020.12.015","volume":"76","author":"CS Kow","year":"2021","unstructured":"Kow CS, Hasan SS. A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19. Therapie. 2021;76(4):361\u20134.","journal-title":"Therapie."},{"key":"1133_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01515-6","author":"BM Bonora","year":"2021","unstructured":"Bonora BM, Avogaro A, Fadini GP. Disentangling conflicting evidence on DPP-4 inhibitors and outcomes of COVID-19: narrative review and meta-analysis. J Endocrinol Invest. 2021. https:\/\/doi.org\/10.1007\/s40618-021-01515-6.","journal-title":"J Endocrinol Invest."},{"issue":"1","key":"1133_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40200-021-00777-4","volume":"20","author":"TI Hariyanto","year":"2021","unstructured":"Hariyanto TI, Kurniawan A. Dipeptidyl peptidase 4 (DPP4) inhibitor and outcome from coronavirus disease 2019 (COVID-19) in diabetic patients: a systematic review, meta-analysis, and meta-regression. J Diabetes Metabolic Disord. 2021;20(1):1\u20138.","journal-title":"J Diabetes Metabolic Disord."},{"key":"1133_CR34","doi-asserted-by":"publisher","first-page":"204201882199648","DOI":"10.1177\/2042018821996482","volume":"12","author":"R Pal","year":"2021","unstructured":"Pal R, Banerjee M, Mukherjee S, Bhogal RS, Kaur A, Bhadada SK. Dipeptidyl peptidase-4 inhibitor use and mortality in COVID-19 patients with diabetes mellitus: an updated systematic review and meta-analysis. Ther Adv Endocrinol Metab. 2021;12:204201882199648.","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"3","key":"1133_CR35","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.dsx.2021.03.027","volume":"15","author":"II Rakhmat","year":"2021","unstructured":"Rakhmat II, Kusmala YY, Handayani DR, et al. Dipeptidyl peptidase-4 (DPP-4) inhibitor and mortality in coronavirus disease 2019 (COVID-19)\u2014a systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr Clin Res Rev. 2021;15(3):777\u201382.","journal-title":"Diabetes Metab Syndr Clin Res Rev"}],"updated-by":[{"DOI":"10.1007\/s13300-021-01154-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000}}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-021-01133-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-021-01133-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-021-01133-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T11:11:07Z","timestamp":1634296267000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-021-01133-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,16]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["1133"],"URL":"https:\/\/doi.org\/10.1007\/s13300-021-01133-8","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,16]]},"assertion":[{"value":"2 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s13300-021-01154-3","URL":"https:\/\/doi.org\/10.1007\/s13300-021-01154-3","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}